QA: Amicus Therapeutics INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2019_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 551,096,000
1 IntangibleAssetsNetIncludingGoodwill 220,800,000
2 PropertyPlantAndEquipmentNet 11,375,000
3 remainder_Assets 6,680,000
4 LiabilitiesCurrent 86,125,000
5 LiabilitiesNoncurrent 2,853,000
6 remainder_Liabilities 358,061,000
7 CostOfGoodsAndServicesSold 14,404,000
8 SellingGeneralAndAdministrativeExpense 265,231,140
9 ResearchAndDevelopmentExpense 878,199,144
10 remainder_Expenses 60,823,924
11 remainder_Revenues 75,423,608
12 remainder_NetIncome 5,694,216
13 remainder_ComprehensiveNetIncome -4,135,290
  yvar yval
0 Assets 789,951,000
1 Liabilities 447,039,000
2 Expenses 1,218,658,208
3 Revenues 75,423,608
4 StockholdersEquity 342,912,000
5 NetIncome -1,137,540,384
6 ComprehensiveNetIncome -1,139,608,029
7 BaseVar 1,270,450,661
8 EconomicCapitalRatiobeforeLimitedLiability -0.634
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time